MedPath

Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes

Active, not recruiting
Conditions
Prematurity
Interventions
Device: Ultrasound
Registration Number
NCT03479515
Lead Sponsor
University of Minnesota
Brief Summary

The overall objective of the proposal is to evaluate the ability of ultrasound to predict the body composition of toddlers in the outpatient clinical setting and to evaluate the relationship between body composition and neurodevelopment.

Detailed Description

The investigators will address the hypothesis in the following Specific Aims:

Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat-free mass in toddlers. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP).

Specific Aim 2: Determine the effect of a handheld Force-Measuring Ultrasound Probe on intra- and inter-observer variability in ultrasound measurements. A device which measures the force applied to the ultrasound probe will be used to obtain measurements of muscle and adipose tissue thickness (biceps, abdomen, and quadriceps) in toddlers.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • toddlers who were ≤ 36 weeks gestational age (GA) at birth who attend the University of Minnesota Masonic Children's Hospital NICU Follow Up Clinic
  • written consent obtained from a parent before or at time of visit
Read More
Exclusion Criteria
  • toddlers who require medical support that prevents them from having ADP measurements taken
  • those with an inability to sit in a supported seat for 5 minutes
  • those weighing less than 10 kg
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Formerly-Premature ToddlersUltrasoundData will be used to create and evaluate predictive equation
Primary Outcome Measures
NameTimeMethod
Ultrasound Measurementsthrough study completion, up to 2 years

Tissue thickness (adipose and muscle) will be measured in cm using the ultrasound probe.

Secondary Outcome Measures
NameTimeMethod
Body Composition Measurementsthrough study completion, up to 2 years

Fat and fat-free mass will be measured in kilograms using bioimpedance and air displacement plethysmography.

Neurodevelopmental Status for 3 and 4 year oldsthrough study completion, up to 2 years

Weschler Preschool and Primary Scale of Intelligence (WPPSI) at 3 and 4 years of age will be used to measure neurodevelopmental status for toddlers 3, 4, or 5 years of age. Quotient and Composite scores have a mean of 100 and a standard deviation of 15. Subtest scaled scores have a mean of 10 and a standard deviation of 3.

Neurodevelopmental Status for 2 year oldsthrough study completion, up to 2 years

Bayley Scales of Neurodevelopment III will be used to measure neurodevelopmental status at 2 years of age, including cognition, language, and motor scores (composite scoring for each area: Cognitive, 55-145; Language, 47-153; Motor, 46-154).

Trial Locations

Locations (1)

University of Minnesota Masonic Children's Hospital

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath